MicroRNA-630 may confer favorable cisplatin-based chemotherapy and clinical outcomes in non-small cell lung cancer by targeting Bcl-2.

Chen MJ, Wu DW, Wang GC, Wang YC, Chen CY, Lee H
Oncotarget. 2018 Feb 9;9(17):13758-13767. doi: 10.18632/oncotarget.24474. eCollection 2018 Mar 2. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.